🔎 Trials Near Me

Home › Lupus Nephritis › Illinois › Chicago

Lupus Nephritis clinical trials in Chicago, IL

9 studies for Lupus Nephritis are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

RecruitingPhase 2
  • University of Chicago, Chicago
Ages 16 to 70 · All sexes · Updated Sep 17, 2026 · NCT07328581

VIBRANT: VIB4920 for Active Lupus Nephritis

RecruitingPhase 2
  • University of Chicago, Department of Medicine: Rheumatology, Chicago
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05201469

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

RecruitingPhase 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
  • University of Chicago Medicine- Comer Children's, Chicago
Ages 8 to 20 · All sexes · Updated Sep 14, 2026 · NCT05538208

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

RecruitingPhase 1/2
  • Research Site, Chicago
Ages 18 to 70 · All sexes · Updated Sep 10, 2026 · NCT06897930

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

RecruitingPhase 1
  • The University of Chicago Medical Center, Chicago
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

RecruitingPhase 1
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Ages 18 to 70 · All sexes · Updated Aug 28, 2026 · NCT06925542

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

RecruitingPhase 1/2
  • Northwestern Memorial Hospital, Chicago
  • The University of Chicago Medical Center, Chicago
Ages 18 to 65 · All sexes · Updated Aug 26, 2026 · NCT06121297

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

RecruitingPhase 1/2
  • Nkarta Investigational Site, Chicago
Ages 18 to 75 · All sexes · Updated Jun 4, 2026 · NCT06557265

Lupus Landmark Study: A Prospective Registry and Biorepository

RecruitingObservational study
  • University of Chicago, Chicago
Ages 18 to 110 · All sexes · Updated Apr 15, 2026 · NCT05934149

Lupus Nephritis trials in other cities

Other studies in Chicago

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.